QA: Albireo Pharma INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001322505_2016_Albireo_Pharma_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001322505, Albireo Pharma INC

  xvar xval
0 AssetsCurrent 41,107,000
1 IntangibleAssetsNetIncludingGoodwill 37,000
2 PropertyPlantAndEquipmentNet 280,000
3 remainder_Assets 0
4 LiabilitiesCurrent 1,808,000
5 LiabilitiesNoncurrent 54,000
6 remainder_Liabilities 5,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,236,831
9 ResearchAndDevelopmentExpense 13,444,065
10 remainder_Expenses 116,915
11 remainder_Revenues 52,692
12 remainder_NetIncome 2,602,718
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 41,424,000
1 Liabilities 1,867,000
2 Expenses 19,797,811
3 Revenues 52,692
4 StockholdersEquity 39,557,000
5 NetIncome -17,142,401
6 ComprehensiveNetIncome -17,142,401
7 BaseVar 32,872,110
8 EconomicCapitalRatiobeforeLimitedLiability 3.19
9 EconomicCapitalRatio 3.82

Edgar->Model Mapping

Feature Distribution

Change over Time